[go: up one dir, main page]

AU2003294235A1 - Fragments and activity of rel protein in m. tuberculosis adn other uses thereof - Google Patents

Fragments and activity of rel protein in m. tuberculosis adn other uses thereof

Info

Publication number
AU2003294235A1
AU2003294235A1 AU2003294235A AU2003294235A AU2003294235A1 AU 2003294235 A1 AU2003294235 A1 AU 2003294235A1 AU 2003294235 A AU2003294235 A AU 2003294235A AU 2003294235 A AU2003294235 A AU 2003294235A AU 2003294235 A1 AU2003294235 A1 AU 2003294235A1
Authority
AU
Australia
Prior art keywords
adn
tuberculosis
fragments
activity
rel protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003294235A
Other versions
AU2003294235A8 (en
Inventor
Andrew Brian Avarbock
David Howard Avarbock
Harvey Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU2003294235A1 publication Critical patent/AU2003294235A1/en
Publication of AU2003294235A8 publication Critical patent/AU2003294235A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003294235A 2002-10-22 2003-10-22 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof Abandoned AU2003294235A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42013102P 2002-10-22 2002-10-22
US60/420,129 2002-10-22
PCT/US2003/033692 WO2004037997A2 (en) 2002-10-22 2003-10-22 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof

Publications (2)

Publication Number Publication Date
AU2003294235A1 true AU2003294235A1 (en) 2004-05-13
AU2003294235A8 AU2003294235A8 (en) 2004-05-13

Family

ID=32176517

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003285946A Abandoned AU2003285946A1 (en) 2002-10-22 2003-10-22 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases
AU2003294235A Abandoned AU2003294235A1 (en) 2002-10-22 2003-10-22 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2003285946A Abandoned AU2003285946A1 (en) 2002-10-22 2003-10-22 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases

Country Status (2)

Country Link
AU (2) AU2003285946A1 (en)
WO (2) WO2004037192A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246349A1 (en) * 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
CN102725290B (en) 2009-07-27 2016-03-09 吉利德科学股份有限公司 As the condensed heterocyclic compouds of ion channel modulators
NZ604478A (en) 2010-07-02 2014-12-24 Gilead Sciences Inc Fused heterocyclic compounds as ion channel modulators
BR112013028886A2 (en) 2011-05-10 2016-08-09 Gilead Sciences Inc fused heterocyclic compounds as sodium channel modulators
TW201837023A (en) 2011-07-01 2018-10-16 美商基利科學股份有限公司 Fused heterocyclic compound as ion channel regulator
NO3175985T3 (en) 2011-07-01 2018-04-28
US9187439B2 (en) 2011-09-21 2015-11-17 Inception Orion, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
CN103232447B (en) * 2013-04-02 2015-06-03 陕西科技大学 3-acetyl-5-acetylimino-2-(N-phenothiazinyl)-1,3,4-thiadiazole, and preparation method and application thereof
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
CN109385439A (en) * 2018-09-18 2019-02-26 上海晶诺生物科技有限公司 The one recombination TM4 phage library and its application for constructing nadh dehydrogenase gene family missing mycobacterium tuberculosis
WO2023201199A2 (en) * 2022-04-11 2023-10-19 The Johns Hopkins University Tuberculosis vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834279A (en) * 1996-03-07 1998-11-10 Trustees Of The University Of Pennsylvania Methods of identifying compounds that inhibit DNA synthesis in mycobacterium tuberculosis and compositions, reagents and kits for performing the same

Also Published As

Publication number Publication date
AU2003294235A8 (en) 2004-05-13
AU2003285946A8 (en) 2004-05-13
AU2003285946A1 (en) 2004-05-13
WO2004037997A2 (en) 2004-05-06
WO2004037192A3 (en) 2006-09-14
WO2004037192A2 (en) 2004-05-06
WO2004037997A3 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
AU2003228393A1 (en) Ehanced protein expression in bacillus
AU2003294235A1 (en) Fragments and activity of rel protein in m. tuberculosis adn other uses thereof
AU2003276937A1 (en) Vegetable protein preparations and use thereof
AU2003216273A1 (en) Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
AU2003280084A1 (en) Protein arrays and uses thereof
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2003250073A1 (en) Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
AU2003235096A1 (en) Novel protein and dna thereof
AU2003280992A1 (en) Novel proteins and use thereof
AU2003292774A1 (en) Novel proteins and use thereof
AU2003275127A1 (en) P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
AU2003303464A1 (en) Centrosome-associated protein and applications thereof
AU2003260487A1 (en) Novel pancortin-pablo protein interactions and methods of use thereof
AU2003262080A1 (en) Novel protein and dna thereof
AU2003292721A1 (en) Novel protein and its gene
AU2003258658A1 (en) Improved dna and proteins
AU2003232513A1 (en) Pain receptor gene and protein
AU2003263751A1 (en) Novel proteins and their uses
AU2003231478A1 (en) Novel protein, its dna and use thereof
AU2003236041A1 (en) Novel protein and dna thereof
AU2003227945A1 (en) Use of minos in functional genomics
AU2003265814A1 (en) Aw755252-interacting proteins and use thereof
AU2003285877A1 (en) Novel proteins and their uses
AU2003220067A1 (en) Jade nucleic acids, proteins and uses thereof
AU2003903934A0 (en) Protein fragments and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase